|
Age (years), median (range)
|
66 (51–80)
|
|
Tumor size (mm), median (range)
|
28 (12–40)
|
|
Sex, n (%)
|
|
Male
|
16 (64.0)
|
|
Female
|
9 (36.0)
|
|
Primary tumor location, n (%)
|
|
Head/neck
|
18 (72.0)
|
|
Body
|
6 (24.0)
|
|
Tail
|
1 (4.0)
|
|
NCCN resectability, n (%)
|
|
Resectable
|
17 (68.0)
|
|
Borderline resectable
|
8 (32.0)
|
|
BR-PV
|
6 (24.0)
|
|
BR-A
|
2 (8.0)
|
|
Completion of NACRT, n (%)
|
23 (92.0)
|
|
Completion of RT, n (%)
|
25 (100.0)
|
|
Completion of CT, n (%)
|
23 (92.0)
|
|
Resection rate, n (%)
|
17 (68.0)
|
|
Reason for protocol failure, n (%)
|
|
Cholangitis
|
1 (4.0)
|
|
Neutropenia
|
1 (4.0)
|
